Seaport Global Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Seaport Global Advisors, LLC

  • $30.9 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$11.69 - $15.02 $334,240 - $429,451
28,592 Added 164.8%
45,941 $537,000
Q2 2023

Aug 14, 2023
BUY
$11.5 - $18.08 $20,136 - $31,658
1,751 Added 11.23%
17,349 $233,000
Q1 2023

May 23, 2023
SELL
$14.34 - $21.05 $75,385 - $110,659
-5,257 Reduced 25.21%
15,598 $258,000
Q4 2022

Feb 14, 2023
BUY
$12.25 - $19.5 $255,473 - $406,672
20,855 New
20,855 $387,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Seaport Global Advisors, LLC Portfolio

Follow Seaport Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaport Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email